Adaptimmune Therapeutics PLC
ADAPY· OTC
Adaptimmune Therapeutics PLC
- Close
- Aug 18, 2026
- Market cap
- $47.71M
- 1.59B shares
- Filings
- 808
Price
Aug 18, 2026 · Official close
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2024 | 2024-12-31 | $178,032,000 | reported | |
| FY 2023 | 2023-12-31 | $60,281,000 | reported | |
| FY 2022 | 2022-12-31 | $27,148,000 | reported | |
| FY 2021 | 2021-12-31 | $6,149,000 | reported | |
| FY 2020 | 2020-12-31 | $3,958,000 | reported | |
| FY 2019 | 2019-12-31 | $1,122,000 | reported | |
| FY 2018 | 2018-12-31 | $59,505,000 | reported | |
| FY 2017 | 2017-12-31 | $37,833,000 | reported | |
| FY 2016 | 2016-12-31 | $14,198,000 | reported | |
| FY 2015 | 2015-06-30 | $9,871,000 | reported | |
| FY 2014 | 2014-06-30 | $825,000 | reported |
Adaptimmune Therapeutics PLC · CIK 1621227 · Engraved from SEC EDGAR
